Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David C Fajgenbaum

Showing results (61-70 of 114) with videos related to

Pageof 12
Sort By:
Blood Advances|February 11, 2021
UCD with MCD-like inflammatory state: surgical excision is highly effectiveMiao-Yan Zhang, Ming-Nan Jia, Jia Chen, et al.
Blood Advances|November 9, 2018
A novel <i>FAS</i> mutation with variable expressivity in a family with unicentric and idiopathic multicentric Castleman diseaseTurner S Baker, Kristyne J Gambino, Lawrence Schriefer, et al.
European Journal of Haematology|August 25, 2021
Novel somatic alterations in unicentric and idiopathic multicentric Castleman diseaseAaron M Goodman, Ah-Reum Jeong, Alexis Phillips, et al.
The New England Journal of Medicine|February 5, 2025
Identifying and Targeting TNF Signaling in Idiopathic Multicentric Castleman's DiseaseMelanie D Mumau, Michael V Gonzalez, Chunyu Ma, et al.
American Journal of Hematology|July 7, 2022
Thrombocytopenia, anasarca, and severe inflammationAmanallah Montazeripouragha, Christine M Campbell, James Russell, et al.
British Journal of Haematology|May 4, 2022
The disease course of Castleman disease patients with fatal outcomes in the ACCELERATE registryDavid C Fajgenbaum, Sheila K Pierson, Karan Kanhai, et al.
British Journal of Haematology|January 3, 2024
Immune-mediated thrombocytopenia and IL-6-mediated thrombocytosis observed in idiopathic multicentric Castleman diseaseAyelet I Rubenstein, Sheila K Pierson, Saishravan Shyamsundar, et al.
Blood|February 15, 2019
Phase 2 study using oral thalidomide-cyclophosphamide-prednisone for idiopathic multicentric Castleman diseaseLu Zhang, Ai-Lin Zhao, Ming-Hui Duan, et al.
Blood Advances|August 14, 2025
A patient-derived CABIN1 mutation recapitulates features of idiopathic multicentric Castleman disease in a mouse modelDorottya Laczko, Patricia Y Tsao, Ruth-Anne Pai, et al.
American Journal of Hematology|April 21, 2018
Plasma proteomics identifies a 'chemokine storm' in idiopathic multicentric Castleman diseaseSheila K Pierson, Aaron J Stonestrom, Dustin Shilling, et al.
Pageof 12

Showing results (61-70 of 114) with videos related to

Sort By:
Pageof 12
Blood Advances|February 11, 2021
UCD with MCD-like inflammatory state: surgical excision is highly effectiveMiao-Yan Zhang, Ming-Nan Jia, Jia Chen, et al.
Blood Advances|November 9, 2018
A novel <i>FAS</i> mutation with variable expressivity in a family with unicentric and idiopathic multicentric Castleman diseaseTurner S Baker, Kristyne J Gambino, Lawrence Schriefer, et al.
European Journal of Haematology|August 25, 2021
Novel somatic alterations in unicentric and idiopathic multicentric Castleman diseaseAaron M Goodman, Ah-Reum Jeong, Alexis Phillips, et al.
The New England Journal of Medicine|February 5, 2025
Identifying and Targeting TNF Signaling in Idiopathic Multicentric Castleman's DiseaseMelanie D Mumau, Michael V Gonzalez, Chunyu Ma, et al.
American Journal of Hematology|July 7, 2022
Thrombocytopenia, anasarca, and severe inflammationAmanallah Montazeripouragha, Christine M Campbell, James Russell, et al.
British Journal of Haematology|May 4, 2022
The disease course of Castleman disease patients with fatal outcomes in the ACCELERATE registryDavid C Fajgenbaum, Sheila K Pierson, Karan Kanhai, et al.
British Journal of Haematology|January 3, 2024
Immune-mediated thrombocytopenia and IL-6-mediated thrombocytosis observed in idiopathic multicentric Castleman diseaseAyelet I Rubenstein, Sheila K Pierson, Saishravan Shyamsundar, et al.
Blood|February 15, 2019
Phase 2 study using oral thalidomide-cyclophosphamide-prednisone for idiopathic multicentric Castleman diseaseLu Zhang, Ai-Lin Zhao, Ming-Hui Duan, et al.
Blood Advances|August 14, 2025
A patient-derived CABIN1 mutation recapitulates features of idiopathic multicentric Castleman disease in a mouse modelDorottya Laczko, Patricia Y Tsao, Ruth-Anne Pai, et al.
American Journal of Hematology|April 21, 2018
Plasma proteomics identifies a 'chemokine storm' in idiopathic multicentric Castleman diseaseSheila K Pierson, Aaron J Stonestrom, Dustin Shilling, et al.
Pageof 12